Literature DB >> 2105890

Prevention of infection and graft-versus-host disease by suppression of intestinal microflora in children treated with allogeneic bone marrow transplantation.

J M Vossen1, P J Heidt, H van den Berg, E J Gerritsen, J Hermans, L J Dooren.   

Abstract

The effect of suppression with antimicrobial agents of the intestinal microflora of paediatric bone marrow graft recipients on severe bacterial and fungal infections and on moderate to severe acute graft-versus-host disease was studied retrospectively. Data on 65 cases of bone marrow transplantation for either severe bone marrow failure or leukaemia, performed in a strict protective environment with either complete or selective gastrointestinal decontamination, were evaluated. All bone marrow grafts were from HLA-identical siblings and were not depleted of T-lymphocytes. Twenty percent of the recipients had one or more episodes of septicaemia during the granulocytopenic period after transplantation, mostly due to gram-positive bacteria. Only five children died due to infection, in each case caused by a microorganism originating from the endogenous flora. Complete gastrointestinal decontamination was superior to selective gastrointestinal decontamination in preventing infectious complications (p less than 0.001). The same was the case for the prevention of acute graft-versus-host disease of grade II or higher, which was observed in 7 of 40 (17.5%) completely decontaminated children versus 9 of 18 (50%) selectively decontaminated children evaluable for graft-versus-host disease (p less than 0.01). It is concluded that complete gastrointestinal decontamination in a strict protective environment is a feasible and very effective method for preventing severe infections and acute graft-versus-host disease after allogeneic bone marrow transplantation in children and adolescents; it resulted in a low transplantation-related mortality of 26% and a good quality of survival in 69% of the graft recipients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105890     DOI: 10.1007/bf01969527

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  34 in total

Review 1.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

2.  Protective isolation and antimicrobial decontamination in patients with high susceptibility to infection. A prospective cooperative study of gnotobiotic care in acute leukemia patients. I: clinical results.

Authors:  M Dietrich; W Gaus; J Vossen; D van der Waaij; F Wendt
Journal:  Infection       Date:  1977       Impact factor: 3.553

3.  Use of oral antibiotics in protected units environment: clinical effectiveness and role in the emergence of antibiotic-resistant strains.

Authors:  J Klastersky; L Debusscher; D Weerts; D Daneau
Journal:  Pathol Biol (Paris)       Date:  1974-01

4.  Streptococcal sepsis in bone marrow transplant patients.

Authors:  J Henslee; B Bostrom; D Weisdorf; N Ramsay; P McGlave; J Kersey
Journal:  Lancet       Date:  1984-02-18       Impact factor: 79.321

5.  Co-trimoxazole versus non-absorbable antibiotics in acute leukaemia.

Authors:  J G Watson; B Jameson; R L Powles; T J McElwain; D N Lawson; I Judson; G R Morgenstern; H Lumley; H E Kay
Journal:  Lancet       Date:  1982-01-02       Impact factor: 79.321

Review 6.  Infections in bone marrow transplant recipients.

Authors:  J W van der Meer; H F Guiot; P J van den Broek; R van Furth
Journal:  Semin Hematol       Date:  1984-04       Impact factor: 3.851

Review 7.  Infection in bone marrow transplantation.

Authors:  J D Meyers; K Atkinson
Journal:  Clin Haematol       Date:  1983-10

8.  A controlled study of isolation and endogenous microbial suppression in acute myelocytic leukemia patients.

Authors:  J W Yates; J F Holland
Journal:  Cancer       Date:  1973-12       Impact factor: 6.860

9.  Protective environment for marrow transplant recipients: a prospective study.

Authors:  C D Buckner; R A Clift; J E Sanders; J D Meyers; G W Counts; V T Farewell; E D Thomas
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

10.  Risk factors for acute graft-versus-host disease.

Authors:  R P Gale; M M Bortin; D W van Bekkum; J C Biggs; K A Dicke; E Gluckman; R A Good; R G Hoffmann; H E Kay; J H Kersey
Journal:  Br J Haematol       Date:  1987-12       Impact factor: 6.998

View more
  41 in total

Review 1.  Intestinal microbiome changes and stem cell transplantation: Lessons learned.

Authors:  Ying Taur
Journal:  Virulence       Date:  2016-11-16       Impact factor: 5.882

Review 2.  Intestinal microbiota-related effects on graft-versus-host disease.

Authors:  Yusuke Shono; Melissa D Docampo; Jonathan U Peled; Suelen M Perobelli; Robert R Jenq
Journal:  Int J Hematol       Date:  2015-03-27       Impact factor: 2.490

3.  Intestinal Blautia Is Associated with Reduced Death from Graft-versus-Host Disease.

Authors:  Robert R Jenq; Ying Taur; Sean M Devlin; Doris M Ponce; Jenna D Goldberg; Katya F Ahr; Eric R Littmann; Lilan Ling; Asia C Gobourne; Liza C Miller; Melissa D Docampo; Jonathan U Peled; Nicholas Arpaia; Justin R Cross; Tatanisha K Peets; Melissa A Lumish; Yusuke Shono; Jarrod A Dudakov; Hendrik Poeck; Alan M Hanash; Juliet N Barker; Miguel-Angel Perales; Sergio A Giralt; Eric G Pamer; Marcel R M van den Brink
Journal:  Biol Blood Marrow Transplant       Date:  2015-05-11       Impact factor: 5.742

4.  The effects of intestinal tract bacterial diversity on mortality following allogeneic hematopoietic stem cell transplantation.

Authors:  Ying Taur; Robert R Jenq; Miguel-Angel Perales; Eric R Littmann; Sejal Morjaria; Lilan Ling; Daniel No; Asia Gobourne; Agnes Viale; Parastoo B Dahi; Doris M Ponce; Juliet N Barker; Sergio Giralt; Marcel van den Brink; Eric G Pamer
Journal:  Blood       Date:  2014-06-17       Impact factor: 22.113

5.  LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation.

Authors:  K R Cooke; A Gerbitz; J M Crawford; T Teshima; G R Hill; A Tesolin; D P Rossignol; J L Ferrara
Journal:  J Clin Invest       Date:  2001-06       Impact factor: 14.808

Review 6.  Antibiotic-mediated modification of the intestinal microbiome in allogeneic hematopoietic stem cell transplantation.

Authors:  J Whangbo; J Ritz; A Bhatt
Journal:  Bone Marrow Transplant       Date:  2016-08-15       Impact factor: 5.483

7.  MHC Class II Antigen Presentation by the Intestinal Epithelium Initiates Graft-versus-Host Disease and Is Influenced by the Microbiota.

Authors:  Motoko Koyama; Pamela Mukhopadhyay; Iona S Schuster; Andrea S Henden; Jan Hülsdünker; Antiopi Varelias; Marie Vetizou; Rachel D Kuns; Renee J Robb; Ping Zhang; Bruce R Blazar; Ranjeny Thomas; Jakob Begun; Nicola Waddell; Giorgio Trinchieri; Robert Zeiser; Andrew D Clouston; Mariapia A Degli-Esposti; Geoffrey R Hill
Journal:  Immunity       Date:  2019-09-18       Impact factor: 31.745

Review 8.  The intestinal microbiota in allogeneic hematopoietic cell transplant and graft-versus-host disease.

Authors:  Anna Staffas; Marina Burgos da Silva; Marcel R M van den Brink
Journal:  Blood       Date:  2016-12-09       Impact factor: 22.113

9.  Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Authors:  Sam C Nalle; H Aimee Kwak; Karen L Edelblum; Nora E Joseph; Gurminder Singh; Galina F Khramtsova; Eric D Mortenson; Peter A Savage; Jerrold R Turner
Journal:  Sci Transl Med       Date:  2014-07-02       Impact factor: 17.956

Review 10.  Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology.

Authors:  P G Falk; L V Hooper; T Midtvedt; J I Gordon
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.